Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in Farnesoid X receptor knockout mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 1, 2011, Pages 12-21

  Wolfe, Andy ^a   Thomas, Ann ^a   Edwards, Genea ^a   Jaseja, Reshma ^a   Guo, Grace L ^a   Apte, Udayan ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DISHEVELLED PROTEIN; FARNESOID X RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; WNT PROTEIN; WNT4 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; KNOCKOUT MOUSE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 79959491395     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.179390     Document Type: Article

References (47)

1. Allen K, Kim ND, Moon JO, and Copple BL (2010) Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 243:63-67.
2. Apte U, Singh S, Zeng G, Cieply B, Virji MA, Wu T, and Monga SP (2009) Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol 175:1056-1065.
3. Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, and Monga SP (2006) Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44:992-1002.
4. Aravalli RN, Steer CJ, and Cressman EN (2008) Molecular mechanisms of hepatocellular carcinoma. Hepatology 48:2047-2063.
5. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, and García De Herreros A (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84-89.
6. Befeler AS and Di Bisceglie AM (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122:1609-1619.
7. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, and Birchmeier W (1993) Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120:757-766.
8. Calvisi DF, Factor VM, Ladu S, Conner EA, and Thorgeirsson SS (2004a) Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. Gastroenterology 126:1374-1386.
9. Calvisi DF, Ladu S, Conner EA, Factor VM, and Thorgeirsson SS (2004b) Disregulation of E-cadherin in transgenic mouse models of liver cancer. Lab Invest 84:1137-1147.
10. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, and Nieto MA (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76-83.
11. Carruba G, Cervello M, Miceli MD, Farruggio R, Notarbartolo M, Virruso L, Giannitrapani L, Gambino R, Montalto G, and Castagnetta L (1999) Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. Ann NY Acad Sci 886:212-216.
12. Devereux TR, Stern MC, Flake GP, Yu MC, Zhang ZQ, London SJ, and Taylor JA (2001) CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol Carcinog 31:68-73.
13. Di Bisceglie AM and Befeler AS (2007) Diagnostic and therapeutic approach to hepatocellular carcinoma in the USA. Hepatol Res 37 (Suppl 2):S251-S253.
14. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, et al. (2005) Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell 19:159-170.
15. Eloranta JJ and Kullak-Ublick GA (2008) The role of FXR in disorders of bile acid homeostasis. Physiology (Bethesda) 23:286-295.
16. El-Serag HB and Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750.
17. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, et al. (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693.
18. Fujie H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, Makuuchi M, Kimura S, and Koike K (2001) Frequent beta-catenin aberration in human hepatocellular carcinoma. Hepatol Res 20:39-51.
19. Fukase K, Ohtsuka H, Onogawa T, Oshio H, Ii T, Mutoh M, Katayose Y, Rikiyama T, Oikawa M, Motoi F, et al. (2008) Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. Cancer Sci 99:1785-1792.
20. Gadaleta RM, van Mil SW, Oldenburg B, Siersema PD, Klomp LW, and van Erpecum KJ (2010) Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim Biophys Acta 1801:683-692.
21. Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB Jr, Kliewer SA, Gonzalez FJ, and Sinal CJ (2003) Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 278:45062-45071.
22. Hu T and Li C (2010) Convergence between Wnt-β-catenin and EGFR signaling in cancer. Mol Cancer 9:236.
23. Huang H, Fujii H, Sankila A, Mahler-Araujo BM, Matsuda M, Cathomas G, and Ohgaki H (1999) Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 155:1795-1801.
24. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, and Moore DD (2006) Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312:233-236.
25. Huber MA, Kraut N, and Beug H (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558.
26. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, and Dent P (2009) Bile acids as regulatory molecules. J Lipid Res 50:1509-1520.
27. Jeanes A, Gottardi CJ, and Yap AS (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27:6920-6929.
28. Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, and Gonzalez FJ (2007a) Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48:2664-2672.
29. Kim I, Morimura K, Shah Y, Yang Q, Ward JM, and Gonzalez FJ (2007b) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28:940-946.
30. Knisely AS, Strautnieks SS, Meier Y, Stieger B, Byrne JA, Portmann BC, Bull LN, Pawlikowska L, Bilezikçi B, Ozçay F, et al. (2006) Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 44:478-486.
31. Kolligs FT, Bommer G, and Göke B (2002) Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66:131-144.
32. Lambert G, Amar MJ, Guo G, Brewer HB Jr, Gonzalez FJ, and Sinal CJ (2003) The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 278:2563-2570.
33. Llovet JM and Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312-1327.
34. Maran RR, Thomas A, Roth M, Sheng Z, Esterly N, Pinson D, Gao X, Zhang Y, Ganapathy V, Gonzalez FJ, et al. (2009) Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J Pharmacol Exp Ther 328:469-477.
35. Modica S, Murzilli S, Salvatore L, Schmidt DR, and Moschetta A (2008) Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res 68:9589-9594.
36. Monga SP, Micsenyi A, Germinaro M, Apte U, and Bell A (2006) β-Catenin regulation during matrigel-induced rat hepatocyte differentiation. Cell Tissue Res 323:71-79.
37. Monga SP, Monga HK, Tan X, Mulé K, Pediaditakis P, and Michalopoulos GK (2003) Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124:202-216.
38. Nuruki K, Toyoyama H, Ueno S, Hamanoue M, Tanabe G, Aikou T, and Ozawa M (1998) E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas. Oncol Rep 5:1109-1114.
39. Pearl LH and Barford D (2002) Regulation of protein kinases in insulin, growth factor and Wnt signalling. Curr Opin Struct Biol 12:761-767.
40. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, and Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-744.
41. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, et al. (2002) Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863-4871.
42. Thomas AM, Hart SN, Kong B, Fang J, Zhong XB, and Guo GL (2010) Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology 51:1410-1419.
43. Thompson MD and Monga SP (2007) WNT/beta-catenin signaling in liver health and disease. Hepatology 45:1298-1305.
44. Trauner M, Claudel T, Fickert P, Moustafa T, and Wagner M (2010) Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 28:220-224.
45. Wang YD, Chen WD, Moore DD, and Huang W (2008) FXR: a metabolic regulator and cell protector. Cell Res 18:1087-1095.
46. Yang F, Huang X, Yi T, Yen Y, Moore DD, and Huang W (2007) Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res 67:863-867.
47. Zeng G, Awan F, Otruba W, Muller P, Apte U, Tan X, Gandhi C, Demetris AJ, and Monga SP (2007) Wnt'er in liver: expression of Wnt and frizzled genes in mouse. Hepatology 45:195-204.